1. Home
  2. CSIQ vs CMPX Comparison

CSIQ vs CMPX Comparison

Compare CSIQ & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

HOLD

Current Price

$18.05

Market Cap

824.4M

Sector

Technology

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSIQ
CMPX
Founded
2001
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
824.4M
927.5M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
CSIQ
CMPX
Price
$18.05
$1.89
Analyst Decision
Hold
Strong Buy
Analyst Count
10
9
Target Price
$17.36
$14.57
AVG Volume (30 Days)
3.1M
12.0M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.61
N/A
Revenue Next Year
$13.90
$934.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$1.61
52 Week High
$34.59
$6.88

Technical Indicators

Market Signals
Indicator
CSIQ
CMPX
Relative Strength Index (RSI) 57.51 27.05
Support Level $12.75 $1.61
Resistance Level $19.26 $3.54
Average True Range (ATR) 1.40 0.17
MACD 0.28 0.05
Stochastic Oscillator 58.80 47.22

Price Performance

Historical Comparison
CSIQ
CMPX

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: